1-2 of 2
Jon Ukropec
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN

Clinical Trials & Observations
Peter M. Voorhees, Cesar Rodriguez, Brandi Reeves, Nitya Nathwani, Luciano J. Costa, Yana Lutska, Padma Bobba, Daniela Hoehn, Huiling Pei, Jon Ukropec, Ming Qi, Thomas S. Lin, Paul G. Richardson
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1092–1096.
https://doi.org/10.1182/bloodadvances.2020003642
Published: 2021
Journal Articles

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Clinical Trials & Observations
Nikhil C. Munshi, Herve Avet-Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur, Meletios Dimopoulos, Margarita Kulakova, Annette Lam, Mahmoud Hashim, Jianming He, Bart Heeg, Jon Ukropec, Jessica Vermeulen, Sarah Cote, Nizar Bahlis
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5988–5999.
https://doi.org/10.1182/bloodadvances.2020002827
Published: 2020
Includes: Supplemental data